English(EN) Clinical Evidence-Guided Residual Learning for Medication Recommendation with Dynamic DDI Regularization

EviDrug框架通过临床证据增强药物推荐

作者 PulseAugur 编辑部 · [1 个来源] · 2026-11-07 09:34

研究人员开发了EviDrug，一个利用临床证据和残差学习的新型药物推荐框架。该系统通过结合自训练的面向访问的编码器和药物集交互模块来整合患者特定的处方。EviDrug提高了预测准确性和药物-药物相互作用正则化，在MIMIC-IV、NWICU和SICdb数据集上优于十二种现有方法。 AI

影响该框架可以通过提供更准确、更安全的药物推荐来改善临床决策。

排序理由该条目是一篇发表在arXiv上的研究论文，详细介绍了一个新的药物推荐框架。[lever_c_demoted from research: ic=1 ai=1.0]

AI 生成摘要 · Google Gemini · 来自 1 个来源。我们如何撰写摘要 →

本文如何被排名

Signal score: 0 / 100; Composite score across the factors below. Higher = stronger signal that this story matters right now.
Newsworthiness bucket: Tool; 该条目是一篇发表在arXiv上的研究论文，详细介绍了一个新的药物推荐框架。[lever_c_demoted from research: ic=1 ai=1.0]
Source corroboration: Single-source cluster; Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.
Topics: paper, model release; Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
AI-industry relevance: High; Clearly on-topic for AI-industry coverage.
Story freshness: 3 days old; Aged out of breaking-news scoring windows; ranking reflects the durable signal from the full source set.

完整方法见我们的编辑标准。

arXiv cs.IR (Information Retrieval) TIER_1 English(EN) · Honggang Qi · 2026-11-07 09:34

基于临床证据的残差学习用于动态 DDI 正则化的药物推荐

Medication recommendation must combine patient-specific treatment evidence with the interaction structure of a prescription. The central challenge is to determine which evidence supports each medication and how strongly to regularize interactions while preserving predictive quali…